Table 3 Cancer cases diagnosed in 2010 attributable to overweight and obesity in 2000

From: 8. Cancers attributable to overweight and obesity in the UK in 2010

    Cases attributable to obesity for each cancer
Age (years) Proportion overweight or obese in 2000 Oesophagus (adenocarcinoma) a,b Gallbladder Pancreas Colon-rectum Breast Corpus uteri Kidney
At exposure At outcome (+10 years) Overweight Obese PAF Obs. Excess attributable cases PAF Obs. Excess attributable cases PAF Obs. Excess attributable cases PAF Obs. Excess attributable cases PAF Obs. Excess attributable cases PAF Obs. Excess attributable cases PAF Obs. Excess attributable cases
Men
 19–24 25–34 0.25 0.18 0.28 4 1 0.13 0 0.0 0.08 9 0.7 0.09 133 11.6        0.17 31 5.3
 24–34 35–44 0.42 0.18 0.33 27 9 0.16 1 0.2 0.10 67 6.8 0.11 397 42.9        0.21 206 42.4
 35–49 45–59 0.45 0.25 0.37 358 134 0.19 24 4.5 0.12 587 71.1 0.13 2921 376.9        0.24 1142 275.9
 50–64 60–74 0.46 0.32 0.41 1405 579 0.21 83 17.6 0.14 1771 244.6 0.15 9481 1392.8        0.27 2368 641.7
 65–74 75–84 0.50 0.24 0.38 963 589 0.19 59 11.5 0.13 1188 149.2 0.13 6774 905.6        0.25 1418 352.7
75 85 0.52 0.17 0.34 371 227 0.17 22 3.8 0.11 460 50.6 0.12 2388 279.7        0.22 472 104.0
Total (%)   5713 1538 (26.9)   191 37.5 (19.7)   4084 523.1 (12.8)   22 127 3009.4 (13.6)         5697 1422.0 (25.0)
Women
 19–24 25–34 0.25 0.14 0.25 1 0.2 0.11 1 0.1 0.07 11 0.8 0.08 136 10.2 0.00 634 0.0 0.24 38 9.0 0.15 29 4.3
 24–34 35–44 0.28 0.16 0.27 4 1.2 0.13 8 1.0 0.08 53 4.2 0.09 402 34.4 0.00 4012 0.0 0.26 211 55.3 0.17 110 18.4
 35–49 45–59 0.31 0.23 0.33 50 16.5 0.16 73 11.6 0.10 437 44.1 0.11 2292 246.8 0.09 15 203 1328.0 0.32 1926 609.2 0.21 554 114.6
 50–64 60–74 0.41 0.22 0.35 267 93.0 0.17 198 34.0 0.11 1520 166.9 0.12 6116 715.3 0.10 18 120 1724.3 0.33 3844 1283.9 0.22 1275 282.5
 65–74 75–84 0.41 0.30 0.39 320 125.9 0.20 143 28.6 0.13 1374 177.4 0.14 5527 759.3 0.11 7855 881.0 0.38 1570 594.8 0.26 903 231.2
75 85 0.41 0.23 0.36 220 78.5 0.18 86 15.2 0.11 884 100.2 0.12 3283 396.3 0.10 4410 433.4 0.34 605 207.2 0.23 428 97.6
Total (%)    2819 315.3 (11.2)   509 90.5 (17.8)   4280 493.6 (11.5)   17 787 2162.4 (12.2)   48 385 4366.7 (9.0)   8195 2759.3 (33.7)   3365 748.6 (22.2)
Persons
 19–24 25–34   0 1.2   1 0.1   20 1.5   269 21.8   634 0.0   38 9.0   60 9.6
 24–34 35–44   31 10.0   9 1.2   120 11.0   799 77.3   4012 0.0   211 55.3   316 60.8
 35–49 45–59   408 150.4   97 16.1   1024 115.3   5213 623.7   15 203 1328.0   1926 609.2   1696 390.5
 50–64 60–74   1672 672.4   281 51.6   3291 411.5   15 597 2108.1   18 120 1724.3   3844 1283.9   3643 924.2
 65–74 75–84   1283 714.4   202 40.0   2562 326.6   12 301 1664.9   7855 881.0   1570 594.8   2321  
75 85   591 305.1   108 19.0   1344 150.8   5671    4410    605 207.2   900  
Total (%)    8532 1853 (21.7)   700 128 (18.3)   8364 1017 (12.2)   39 914 5172 (13.0)   48 385 4367 (9.0)   8195 2759 (33.7)   9062 2171 (24.0)
  1. Abbreviations: Obs=observed cases; PAF=population-attributable fraction.
  2. Observed cases are for adenocarcinoma only.
  3. Total observed cases (and percentages) are for all oesophageal cancers, and so are greater than the sum of observed cases.